,"Author: Laruelle, Marc A.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 47 (Of the 141 documents considered for the h-Index, 47 have been cited at least 47 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,6005,1068,1082,2150,822,8977
2009,"In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice","Rabiner E.A., Gentile G., Gunn R.N., Laruelle M.A., Slifstein M., Nobrega J., Plisson C., Huiban M., Raymond R., Diwan M., Wilson A.A., McCormick P.",08874476,"Synapse",63, 9,0,0,0,0,1,1
2009,"Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies","Bennacef I., Huang Y., Holmes I., Micheli F., Heidbreder C., Gentile G., Rossi T., Laruelle M., Salinas C.A., Bonasera T.A., Gunn R.N., Audrain H., Jakobsen S., Nabulsi N., Weinzimmer D., Carson R.E.",0960894X,"Bioorganic and Medicinal Chemistry Letters",19, 17,0,0,0,0,0,0
2009,"Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naïve Schizophrenic Subjects","Abi-Dargham A., van de Giessen E., Slifstein M., Kegeles L.S., Laruelle M.",00063223,"Biological Psychiatry",65, 12,0,0,0,0,0,0
2009,"Kinetic modeling of11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo","Marner L., Gunn R.N., Laruelle M., Knudsen G.M., Gillings N., Comley R.A., Baare W.F.C., Rabiner E.A., Wilson A.A., Houle S., Hasselbalch S.G., Svarer C.",01615505,"Journal of Nuclear Medicine",50, 6,0,0,0,0,0,0
2009,"Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine","Martinez D., Kleber H.D., Laruelle M., Slifstein M., Narendran R., Foltin R.W., Broft A., Hwang D.-R., Perez A., Abi-Dargham A., Fischman M.W.",0893133X,"Neuropsychopharmacology",34, 7,0,0,0,0,0,0
2009,"Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET","Catafau A.M., Suarez M., Bullich S., Llop J., Nucci G., Gunn R.N., Brittain C., Laruelle M.",10538119,"NeuroImage",46, 2,0,0,0,0,0,0
2009,"Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [ 11C]fallypride","Narendran R., Cooper T.B., Mathis C.A., Laruelle M., Frankle W.G., Mason N.S., Rabiner E.A., Gunn R.N., Searle G.E., Vora S., Litschge M., Kendro S.",08874476,"Synapse",63, 6,0,0,0,0,1,1
2009,"Dopamine transporters, D2 receptors, and Dopamine release in generalized social anxiety disorder","Schneier F.R., Abi-Dargham A., Martinez D., Slifstein M., Hwang D.-R., Liebowitz M.R., Laruelle M.",10914269,"Depression and Anxiety",26, 5,0,0,0,0,0,0
2009,"Positron Emission Tomography Imaging of the Serotonin Transporter and 5-HT1A Receptor in Alcohol Dependence","Martinez D., Abi-Dargham A., Slifstein M., Gil R., Hwang D.-R., Huang Y., Perez A., Frankle W.G., Laruelle M., Krystal J.",00063223,"Biological Psychiatry",65, 2,0,0,0,0,1,1
2008,"Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F] fallypride","Kegeles L.S., Gil R., Laruelle M., Abi-Dargham A., Slifstein M., Frankle W.G., Xu X., Hackett E., Bae S.-A., Gonzales R., Kim J.-H., Alvarez B.",0893133X,"Neuropsychopharmacology",33, 13,0,0,0,0,6,6
2008,"COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET","Slifstein M., Abi-Dargham A., Kolachana B., Simpson E.H., Tabares P., Cheng B., Duvall M., Gordon Frankle W., Weinberger D.R., Laruelle M.",13594184,"Molecular Psychiatry",13, 8,0,0,6,6,9,15
2008,"D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: An open-label study in patients with schizophrenia","Mamo D., Kapur S., Keshavan M., Laruelle M., Taylor C.C., Kothare P.A., Barsoum P., McDonnell D.",0893133X,"Neuropsychopharmacology",33, 2,0,0,4,4,4,8
2007,"PET and microdialysis measurement of dopamine release in striatum and extrastriatal brain regions following amphetamine","Slifstein M., Moore H., Kegeles L., Laruelle M., Abi-Dargham A.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",27, 1,0,0,0,0,0,0
2007,"Graphical analysis of occupancy studies","Cunningham V.J., Gunn R.N., Rabiner E., Slifstein M., Laruelle M.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",27, 1,0,0,0,0,0,0
2007,"The surface D2-binding profile of the atypical antipsychotic drug amisulpride","Guo N., Guo W., Guillin O., Laruelle M., Javitch J., Rayport S.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",27, 1,0,0,0,0,0,0
2007,"Combining PET and equilibrium dialysis to assess blood brain barrier transport","Gunn R., Jeffrey P., Laruelle M., Summerfield S., Salinas C., Read K., Searle G., Ruffo A., Parker C., Stevens A., Bonasera T.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",27, 1,0,0,0,0,0,0
2007,"[11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT2A receptors: A PET study in healthy human subjects","Slifstein M., Kegeles L.S., Gonzales R., Frankle W.G., Xu X., Laruelle M., Abi-Dargham A.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",27, 10,0,0,2,2,4,6
2007,"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","Innis R.B., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Cunningham V.J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Delforge J., Carson R.E., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.-C.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",27, 9,0,3,55,58,63,121
2007,"In vivo DA D1 receptor selectivity of NNC 112 and SCH 23390","Ekelund J., Laruelle M., Slifstein M., Narendran R., Guillin O., Belani H., Guo N.-N., Hwang Y., Hwang D.-R., Abi-Dargham A.",15361632,"Molecular Imaging and Biology",9, 3,0,1,3,4,4,8
2007,"Amphetamine-induced dopamine release: Markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine","Martinez D., Kleber H.D., Laruelle M., Narendran R., Foltin R.W., Slifstein M., Hwang D.-R., Broft A., Huang Y., Cooper T.B., Fischman M.W.",0002953X,"American Journal of Psychiatry",164, 4,0,4,13,17,14,31
2007,"Neurobiology of Dopamine in Schizophrenia","Guillin O., Abi-Dargham A., Laruelle M.",00747742,"International Review of Neurobiology",78, ,0,2,13,15,12,27
2007,"Amphetamine-induced dopamine release: Duration of action as assessed with the D2/3 receptor agonist radiotracer (-)-N-[11C]propyl- norapomorphine ([11C]NPA) in an anesthetized nonhuman primate","Narendran R., Slifstein M., Hwang D.-R., Hwang Y., Scher E., Reeder S., Martinez D., Laruelle M.",08874476,"Synapse",61, 2,0,1,2,3,2,5
2006,"Dopamine (D2/3) receptor agonist Positron Emission Tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo","Narendran R., Slifstein M., Guillin O., Hwang Y., Hwang D.-R., Scher E., Reeder S., Rabiner E., Laruelle M.",08874476,"Synapse",60, 7,0,3,11,14,9,23
2006,"Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: A positron emission tomography imaging study with [11C]WAY 100635","Frankle W.G., Gil R., Laruelle M., Abi-Dargham A., Lombardo I., Kegeles L.S., Slifstein M., Martin J.H., Huang Y., Hwang D.-R., Reich E., Cangiano C.",00333158,"Psychopharmacology",189, 2,0,5,4,9,4,13
2006,"Estimation of serotonin transporter parameters with11C-DASB in healthy humans: Reproducibility and comparison of methods","Frankle W.G., Slifstein M., Gunn R.N., Huang Y., Hwang D.-R., Darr E.A., Narendran R., Abi-Dargham A., Laruelle M.",01615505,"Journal of Nuclear Medicine",47, 5,0,7,6,13,4,17
2006,"Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography","Van Berckel B.N.M., Kegeles L.S., Waterhouse R., Guo N., Hwang D.-R., Huang Y., Narendran R., Van Heertum R., Laruelle M.",0893133X,"Neuropsychopharmacology",31, 5,0,3,3,6,4,10
2006,"Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET","Slifstein M., Hwang D.-R., Martinez D., Ekelund J., Huang Y., Hackett E., Abi-Dargham A., Laruelle M.",01615505,"Journal of Nuclear Medicine",47, 2,0,2,5,7,2,9
2005,"11C-GR103545, a radiotracer for imaging ?-opioid receptors in vivo with PET: Synthesis and evaluation in baboons","Talbot P.S., Narendran R., Butelman E.R., Huang Y., Ngo K., Slifstein M., Martinez D., Laruelle M., Hwang D.-R.",01615505,"Journal of Nuclear Medicine",46, 3,4,5,5,10,0,14
2005,"Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene","Van Dyck C.H., Malison R.T., Jacobsen L.K., Seibyl J.P., Staley J.K., Laruelle M., Baldwin R.M., Innis R.B., Gelernter J.",01615505,"Journal of Nuclear Medicine",46, 5,6,16,11,27,15,48
2005,"Striatal dopamine transporter availability with [123I]?-CIT SPECT is unrelated to gender or menstrual cycle","Best S.E., Sarrel P.M., Malison R.T., Laruelle M., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Innis R.B., Van Dyck C.H.",00333158,"Psychopharmacology",183, 2,0,4,5,9,6,15
2005,"Neuroreceptor Imaging in Psychiatry: Theory and Applications","Frankle W.G., Slifstein M., Talbot P.S., Laruelle M.",00747742,"International Review of Neurobiology",67, ,1,1,1,2,0,3
2005,"Altered prefrontal dopaminergic function in chronic recreational ketamine users","Narendran R., Hwang D.-R., Khenissi L., Cooper T.B., Laruelle M., Abi-Dargham A., Gordon Frankle W., Keefe R., Gil R., Martinez D., Slifstein M., Kegeles L.S., Talbot P.S., Huang Y.",0002953X,"American Journal of Psychiatry",162, 12,4,11,5,16,5,25
2005,"Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum","Martinez D., Krystal J., Laruelle M., Abi-Dargham A., Gil R., Slifstein M., Hwang D.-R., Huang Y., Perez A., Kegeles L., Talbot P., Evans S.",00063223,"Biological Psychiatry",58, 10,8,13,20,33,11,52
2005,"Synthesis of potent and selective serotonin 5-HT1B receptor ligands","Huang Y., Bae S.-A., Roth B.L., Laruelle M.",0960894X,"Bioorganic and Medicinal Chemistry Letters",15, 21,1,2,1,3,1,5
2005,"Mechanism of action of antipsychotic drugs: From dopamine D2 receptor antagonism to glutamate NMDA facilitation","Laruelle M., Frankle W.G., Narendran R., Kegeles L.S., Abi-Dargham A.",01492918,"Clinical Therapeutics",27, 1,7,10,9,19,11,37
2005,"Epibatidine analogues as selective ligands for the ? x?2-containing subtypes of nicotinic acetylcholine receptors","Huang Y., Zhu Z., Xiao Y., Laruelle M.",0960894X,"Bioorganic and Medicinal Chemistry Letters",15, 19,4,4,1,5,1,10
2005,"Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: A positron emission tomography study using [11C]N-propyl-norapomorphine and [11C] raclopride in baboons","Narendran R., Laruelle M., Hwang D.-R., Slifstein M., Hwang Y., Huang Y., Ekelund J., Guillin O., Scher E., Martinez D.",00223565,"Journal of Pharmacology and Experimental Therapeutics",315, 1,5,3,3,6,6,17
2005,"Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia","Cho R.Y., Ford J.M., Krystal J.H., Laruelle M., Cuthbert B., Carter C.S.",05867614,"Schizophrenia Bulletin",31, 4,1,2,0,2,0,3
2005,"A positron emission tomography radioligand for the in vivo labeling of metabotropic glutamate 1 receptor: (3-Ethyl-2-[11C]methyl-6- quinolinyl)(cis-4-methoxycyclohexyl)methanone","Huang Y., Narendran R., Bischoff F., Guo N., Zhu Z., Bae S.-A., Lesage A.S., Laruelle M.",00222623,"Journal of Medicinal Chemistry",48, 16,2,3,1,4,1,7
2005,"Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder","Kent J.M., Gorman J.M., Coplan J.D., Mawlawi O., Martinez J.M., Browne S.T., Slifstein M., Martinez D., Abi-Dargham A., Laruelle M.",0002953X,"American Journal of Psychiatry",162, 7,4,9,6,15,1,20
2005,"Serotonin transporter availability in patients with schizophrenia: A positron emission tomography imaging study with [11C]DASB","Frankle W.G., Narendran R., Huang Y., Hwang D.-R., Lombardo I., Cangiano C., Gil R., Laruelle M., Abi-Dargham A.",00063223,"Biological Psychiatry",57, 12,7,6,0,6,2,15
2005,"Brain serotonin transporter distribution in subjects with impulsive aggressivity: A positron emission study with [11C]McN 5652","Frankle W.G., Abi-Bargham A., Laruelle M., Siever L.J., Lombardo I., New A.S., Goodman M., Talbot P.S., Huang Y., Hwang D.-R., Slifstein M., Curry S.",0002953X,"American Journal of Psychiatry",162, 5,10,18,26,44,12,66
2005,"Fluorinated diaryl sulfides as serotonin transporter ligands: Synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents","Huang Y., Bae S.-A., Zhu Z., Guo N., Roth B.L., Laruelle M.",00222623,"Journal of Medicinal Chemistry",48, 7,3,5,10,15,4,22
2005,"Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans","Talbot P.S., Frankle W.G., Hwang D.-R., Huang Y., Suckow R.F., Slifstein M., Abi-Dargham A., Laruelle M.",08874476,"Synapse",55, 3,7,11,6,17,5,29
2005,"Positron-labeled dopamine agonists for probing the high affinity states of dopamine subtype 2 receptors","Hwang D.-R., Narendran R., Laruelle M.",10431802,"Bioconjugate Chemistry",16, 1,6,3,2,5,1,12
2005,"Mechanisms of action of second generation antipsychotic drugs in schizophrenia: Insights from brain imaging studies","Abi-Dargham A., Laruelle M.",09249338,"European Psychiatry",20, 1,12,13,16,29,4,45
2004,"The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics","Zhu Z., Guo N., Narendran R., Erritzoe D., Ekelund J., Hwang D.-R., Bae S.-A., Laruelle M., Huang Y.",09698051,"Nuclear Medicine and Biology",31, 8,5,2,6,8,2,15
2004,"Effect of amphetamine on [18F]fallypride in vivo binding to D2 receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies","Slifstein M., Narendran R., Hwang D.-R., Sudo Y., Talbot P.S., Huang Y., Laruelle M.",08874476,"Synapse",54, 1,9,4,5,9,6,24
2004,"In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)- N?-(3-methoxy-phenyl)-N?-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor","Waterhouse R.N., Slifstein M., Dumont F., Zhao J., Chang R.C., Sudo Y., Sultana A., Balter A., Laruelle M.",09698051,"Nuclear Medicine and Biology",31, 7,1,1,0,1,0,2
2004,"Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: Theoretical implications","Frankle W.G., Gorman J.M., Laruelle M., Abi-Dargham A., Gil R., Hackett E., Mawlawi O., Zea-Ponce Y., Zhu Z., Kochan L.D., Cangiano C., Slifstein M.",00333158,"Psychopharmacology",175, 4,6,5,6,11,4,21
2004,"A PET imaging agent with fast kinetics: Synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2- dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA)","Huang Y., Narendran R., Bae S.-A., Erritzoe D., Guo N., Zhu Z., Hwang D.-R., Laruelle M.",09698051,"Nuclear Medicine and Biology",31, 6,5,1,9,10,3,18
2004,"A new positron emission tomography imaging agent for the serotonin transporter: Synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5- fluoromethylphenylamine ([11C]AFM)","Huang Y., Hwang D.-R., Bae S.-A., Sudo Y., Guo N., Zhu Z., Narendran R., Laruelle M.",09698051,"Nuclear Medicine and Biology",31, 5,8,1,7,8,3,19
2004,"Cocaine and dependence and D2 receptor availability in the functional subdivisions of the striatum: Relationship with cocaine-seeking behavior","Martinez D., Kleber H.D., Fischman M.W., Laruelle M., Broft A., Foltin R.W., Slifstein M., Hwang D.-R., Huang Y., Perez A., Frankel W.G., Cooper T.",0893133X,"Neuropsychopharmacology",29, 6,16,13,12,25,7,48
2004,"In Vivo Vulnerability to Competition by Endogenous Dopamine: Comparison of the D2 Receptor Agonist Radiotracer (-)-N-[ 11C]propyl-norapomorphine ([11C]NPA) with the D 2 Receptor Antagonist Radiotracer [11C]-Raclopride","Narendran R., Abi-Dargham A., Laruelle M., Hwang D.-R., Slifstein M., Talbot P.S., Erritzoe D., Huang Y., Cooper T.B., Martinez D., Kegeles L.S.",08874476,"Synapse",52, 3,24,10,8,18,10,52
2004,"Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide","Abi-Dargham A., Cooper T., Laruelle M., Siever L.J., Kegeles L.S., Zea-Ponce Y., Mawlawi O., Martinez D., Mitropoulou V., O'Flynn K., Koenigsberg H.W., Van Heertum R.",00063223,"Biological Psychiatry",55, 10,6,3,7,10,5,21
2004,"Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans","Frankle W.G., Huang Y., Hwang D.-R., Talbot P.S., Slifstein M., Van Heertum R., Abi-Dargham A., Laruelle M.",01615505,"Journal of Nuclear Medicine",45, 4,20,13,8,21,9,50
2004,"Central Serotonin Transporter Availability Measured with [ 123I]?-CIT SPECT in Relation to Serotonin Transporter Genotype","Van Dyck C.H., Malison R.T., Staley J.K., Jacobsen L.K., Seibyl J.P., Laruelle M., Baldwin R.M., Innis R.B., Gelernter J.",0002953X,"American Journal of Psychiatry",161, 3,24,8,14,22,9,55
2004,"Pharmacological and Genetic Characterization of Two Selective Serotonin Transporter Ligands: 2-[2-(Dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-Amino-4-[2-(dimethylaminomethylphenylthio)]benzonitrile (DASB)","Li Q., Ma L., Innis R.B., Seneca N., Ichise M., Huang H., Laruelle M., Murphy D.L.",00223565,"Journal of Pharmacology and Experimental Therapeutics",308, 2,4,1,1,2,0,6
2004,"Quantitative analysis of (-)-N-11C-propyl-norapomorphine in vivo binding in nonhuman primates","Hwang D.-R., Laruelle M., Narendran R., Huang Y., Slifstein M., Talbot P.S., Sudo Y., Van Berckel B.N., Kegeles L.S., Martinez D.",01615505,"Journal of Nuclear Medicine",45, 2,10,3,6,9,2,21
2003,"Serotonin transporters in obsessive-compulsive disorder: A positron emission tomography study with [11C]McN 5652","Simpson H.B., Lombardo I., Slifstein M., Huang H.Y., Hwang D.-R., Abi-Dargham A., Liebowitz M.R., Laruelle M.",00063223,"Biological Psychiatry",54, 12,14,9,9,18,2,34
2003,"Imaging drug action in schizophrenia: Research update","Laruelle M., Abi-Dargham A.",09249338,"European Psychiatry",18, 2,1,0,0,0,0,1
2003,"Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: Results from a large cohort","Abi-Dargham A., Kegeles L.S., Martinez D., Innis R.B., Laruelle M.",0924977X,"European Neuropsychopharmacology",13, 6,11,5,2,7,2,20
2003,"Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography","Laruelle M., Slifstein M., Huang Y.",15361632,"Molecular Imaging and Biology",5, 6,25,8,12,20,5,50
2003,"Glutamate, Dopamine, and Schizophrenia from Pathophysiology to Treatment","Laruelle M., Kegeles L.S., Abi-Dargham A.",00778923,"Annals of the New York Academy of Sciences",1003, ,64,33,19,52,25,141
2003,"Dopamine depletion and in vivo binding of PET D1 receptor radioligands: Implications for imaging studies in schizophrenia","Guo N., Hwang D.-R., Lo E.-S., Huang Y.-Y., Laruelle M., Abi-Dargham A.",0893133X,"Neuropsychopharmacology",28, 9,17,7,5,12,3,32
2003,"Measurement of Neurotransmitters with Positron Emission Tomography","Laruelle M., Erritzoe D., Abi-Dargham A., Huang Y.",09281258,"Medecine Nucleaire",27, 9,0,0,0,0,0,0
2003,"The synaptic hypothesis of Schizophrenia","Frankle W.G., Lerma J., Laruelle M.",08966273,"Neuron",39, 2,30,13,13,26,4,60
2003,"Synthesis and in vivo evaluation of [11C]zolpidem, an imidazopyridine with agonist properties at central benzodiazepine receptors","Dumont F., Waterhouse R.N., Montoya J.A., Mattner F., Katsifis A., Kegeles L.S., Laruelle M.",09698051,"Nuclear Medicine and Biology",30, 4,5,1,3,4,1,10
2003,"Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum","Martinez D., Abi-Dargham A., Haber S.N., Laruelle M., Slifstein M., Broft A., Mawlawi O., Hwang D.-R., Huang Y., Cooper T., Kegeles L., Zarahn E.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",23, 3,48,22,14,36,24,108
2003,"Evaluation of [3H]LY341495 for labeling group II metabotropic glutamate receptors in vivo","Waterhouse R.N., Schmidt M.E., Sultana A., Schoepp D.D., Wheeler W.J., Mozley P.D., Laruelle M.",09698051,"Nuclear Medicine and Biology",30, 2,1,1,0,1,0,2
2002,"Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: A positron emission tomography study with [11C]McN 5652","Kent J.M., Gorman J.M., Laruelle M., Coplan J.D., Lombardo I., Hwang D.-R., Huang Y., Mawlawi O., Van Heertum R.L., Slifstein M., Abi-Dargham A.",00333158,"Psychopharmacology",164, 4,14,2,6,8,7,29
2002,"The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development","Talbot P.S., Laruelle M.",0924977X,"European Neuropsychopharmacology",12, 6,23,9,10,19,6,48
2002,"Neuroreceptor imaging in psychiatric disorders","Frankle G.W., Laruelle M.",09147187,"Annals of Nuclear Medicine",16, 7,14,5,3,8,2,24
2002,"In vivo evaluation of [11C]-3-[2-[(3-methoxyphenylamino)carbonyl]ethenyl]-4,6- dichloroindole-2-carboxylic acid ([11C]3MPICA) as a PET radiotracer for the glycine site of the NMDA ion channel","Waterhouse R.N., Sultana A., Laruelle M.",09698051,"Nuclear Medicine and Biology",29, 8,6,1,0,1,0,7
2002,"Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM","Huang Y., Kung H.F., Laruelle M., Hwang D.-R., Narendran R., Sudo Y., Chatterjee R., Bae S.-A., Mawlawi O., Kegeles L.S., Wilson A.A.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",22, 11,53,12,12,24,3,80
2002,"Synthesis of [11C] N-(2-chloro-5-thiomethylphenyl)-N?-(3-methoxyphenyl)- N?-methylguanidine ([11C]GMOM): A candidate PET tracer for imaging the PCP site of the NMDA ion channel","Waterhouse R.N., Dumont F., Sultana A., Simpson N., Laruelle M.",03624803,"Journal of Labelled Compounds and Radiopharmaceuticals",45, 11,4,1,1,2,0,6
2002,"Positron emission tomography: Imaging and quantification of neurotransporter availability","Laruelle M., Slifstein M., Huang Y.",10462023,"Methods",27, 3,19,5,7,12,4,35
2002,"Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA)","Huang Y., Hwang D.-R., Zhu Z., Bae S.-A., Guo N., Sudo Y., Kegeles L.S., Laruelle M.",09698051,"Nuclear Medicine and Biology",29, 7,16,0,6,6,1,23
2002,"Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT2A/2C serotonin agonist","Zea-Ponce Y., Kegeles L.S., Guo N., Raskin L., Bakthavachalam V., Laruelle M.",09698051,"Nuclear Medicine and Biology",29, 5,3,0,1,1,0,4
2002,"Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia","Abi-Dargham A., Van Heertum R., Gorman J.M., Laruelle M., Mawlawi O., Lombardo I., Gil R., Martinez D., Huang Y., Hwang D.-R., Keilp J., Kochan L.",02706474,"Journal of Neuroscience",22, 9,130,46,31,77,18,225
2002,"Cognitive and brain function in schizotypal personality disorder","Siever L.J., Koenigsberg H.W., Harvey P., Mitropoulou V., Laruelle M., Abi-Dargham A., Goodman M., Buchsbaum M.",09209964,"Schizophrenia Research",54, 1-2,43,8,9,17,3,63
2002,"Synthesis and characterization of 4,6-dichloroindole-based radioligands for imaging the glycine site of the NMDA ion channel","Waterhouse R.N., Sultana A., Guo N., Lee B., Simpson N., Collier L., Laruelle M.",03624803,"Journal of Labelled Compounds and Radiopharmaceuticals",45, 2,2,0,1,1,0,3
2002,"Age-related decline in dopamine transporters: Analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries","Van Dyck C.H., Seibyl J.P., Malison R.T., Laruelle M., Zoghbi S.S., Baldwin R.M., Innis R.B.",10647481,"American Journal of Geriatric Psychiatry",10, 1,47,11,8,19,5,71
2002,"NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans","Kegeles L.S., Martinez D., Kochan L.D., Hwang D.-R., Huang Y., Mawlawi O., Suckow R.F., Van Heertum R.L., Laruelle M.",08874476,"Synapse",43, 1,26,4,3,7,8,41
2001,"Imaging neurochemical endophenotypes: Promises and pitfalls","Martinez D., Broft A., Laruelle M.",14622416,"Pharmacogenomics",2, 3,11,1,3,4,0,15
2001,"Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D2 receptor parameter measurements in ventral striatum","Mawlawi O., Van Heertum R., Laruelle M., Martinez D., Slifstein M., Broft A., Chatterjee R., Hwang D.-R., Huang Y., Simpson N., Ngo K.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",21, 9,65,18,29,47,14,126
2001,"Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression","Parsey R.V., Laruelle M., Oquendo M.A., Zea-Ponce Y., Rodenhiser J., Kegeles L.S., Pratap M., Cooper T.B., Van Heertum R., Mann J.John",00063223,"Biological Psychiatry",50, 5,31,12,6,18,7,56
2001,"Vulnerability of positron emission tomography radiotracers to endogenous competition: New insights","Laruelle M., Huang Y.",11243937,"Quarterly Journal of Nuclear Medicine",45, 2,16,1,1,2,4,22
2001,"Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers","Slifstein M., Laruelle M.",09698051,"Nuclear Medicine and Biology",28, 5,35,11,12,23,9,67
2001,"Synthesis of potent and selective dopamine D4 antagonists as candidate radioligands","Huang Y., Kegeles L.S., Bae S.-A., Hwang D.-R., Roth B.L., Savage J.E., Laruelle M.",0960894X,"Bioorganic and Medicinal Chemistry Letters",11, 11,4,1,0,1,0,5
2001,"How does pindolol improve antidepressant action?","Artigas F., Celada P., Laruelle M., Adell A.",01656147,"Trends in Pharmacological Sciences",22, 5,77,7,7,14,6,97
2001,"The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans","Martinez D., Gelernter J., Abi-Dargham A., Van Dyck C.H., Kegeles L., Innis R.B., Laruelle M.",0893133X,"Neuropsychopharmacology",24, 5,58,18,9,27,9,94
2001,"Differential occupancy of somatodendritic and postsynaptic 5HT1A receptors by pindolol: A dose-occupancy study with [11C]WAY 100635 and Positron Emission Tomography in humans","Martinez D., Shinn A., Van Heertum R., Abi-Dargham A., Caltabiano S., Malizia A., Cowley H., Mann J.J., Laruelle M., Hwang D.-R., Mawlawi O., Slifstein M., Kent J., Simpson N., Parsey R.V., Hashimoto T., Huang Y.",0893133X,"Neuropsychopharmacology",24, 3,58,8,6,14,1,73
2001,"Detachment and generalized social phobia [9] (multiple letters)","Schneier F.R., Liebowitz M.R., Laruelle M., Laakso A., Hietala J.",0002953X,"American Journal of Psychiatry",158, 2,4,0,1,1,1,6
2000,"The role of model-based methods in the development of single scan techniques","Laruelle M.",09698051,"Nuclear Medicine and Biology",27, 7,6,2,1,3,2,11
2000,"A new D2 agonist PET ligand, [C-11]NPA","Hwang D.R., Kegeles L.S., Laruelle M.",10538119,"NeuroImage",11, 6,1,0,0,0,0,1
2000,"Effects of statistical noise on graphic analysis of PET neuroreceptor studies","Slifstein M., Laruelle M.",01615505,"Journal of Nuclear Medicine",41, 12,51,13,13,26,9,86
2000,"Wavelet denoising of PET images: Effect on the accuracy of the AIR algorithm","Mawlawi O., Chatarjee A., Slifstein M., Laruelle M.",10538119,"NeuroImage",11, 6,1,0,0,0,0,1
2000,"[11C]raclopride PET measurement of mesolimbic and nigrostriatal ketamine-induced dopamine release in healthy humans","Kegeles L.S., Mann J.J., Van Heertum R., Laruelle M., Martinez D., Kochan L.D., Simpson N., Hwang D.R., Mawlawi O., Weiss R., Pratap M., Suckow R.F.",10538119,"NeuroImage",11, 6,1,0,0,0,0,1
2000,"Differential occupancy of 5HT-1A autoreceptors and post-synaptic receptors by pindolol in humans measured with PET and [11C-carbonyl] WAY 100635","Martinez D., Malizia A., Cowley H., Laruelle M., Hwang D.-R., Mawlawi O., Kent J., Hashimoto T., Van Heertum R., Abi-Dargham A., John Mann J., Caltabiano S.",10538119,"NeuroImage",11, 6,1,0,0,0,0,1
2000,"(-)-N-[11C]propyl-norapomorphine: A positron-labeled dopamine agonist for PET imaging of D2 receptors","Hwang D.-R., Kegeles L.S., Laruelle M.",09698051,"Nuclear Medicine and Biology",27, 6,26,2,2,4,4,34
2000,"Pindolol augmentation of antidepressant treatment: Recent contributions from brain imaging studies","Martinez D., Broft A., Laruelle M.",00063223,"Biological Psychiatry",48, 8,34,2,1,3,0,37
2000,"In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652","Parsey R.V., Laruelle M., Kegeles L.S., Hwang D.-R., Simpson N., Abi-Dargham A., Mawlawi O., Slifstein M., Van Heertum R.L., Mann J.J.",01615505,"Journal of Nuclear Medicine",41, 9,77,6,9,15,5,97
2000,"Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia","Kegeles L.S., Abi-Dargham A., Zea-Ponce Y., Rodenhiser-Hill J., Mann J.J., Van Heertum R.L., Cooper T.B., Carlsson A., Laruelle M.",00063223,"Biological Psychiatry",48, 7,75,17,13,30,12,117
2000,"Validation and reproducibility of measurement of 5-HT(1A) receptor parameters with [carbonyl-11 C]WAY-100635 in humans: Comparison of arterial and reference tissue input functions","Parsey R.V., Laruelle M., Slifstein M., Hwang D.-R., Abi-Dargham A., Simpson N., Mawlawi O., Guo N.-N., Van Heertum R., John Mann J.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",20, 7,66,15,7,22,7,95
2000,"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","Abi-Dargham A., Van Heertum R.L., Gorman J.M., Laruelle M., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., Weiss R., Cooper T.B., Mann J.J.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",97, 14,188,39,42,81,30,299
2000,"Derivation of [11C]WAY-100635 binding parameters with reference tissue models: Effect of violations of model assumptions","Slifstein M., Parsey R.V., Laruelle M.",09698051,"Nuclear Medicine and Biology",27, 5,29,1,3,4,4,37
2000,"Positron emission tomography study of pindolol occupancy of 5-HT(1A) receptors in humans: Preliminary analyses","Martinez D., Van Heertum R., Abi-Dargham A., Caltabiano S., Malizia A., Cowley H., Mann J.J., Laruelle M., Mawlawi O., Hwang D.-R., Kent J., Simpson N., Parsey R.V., Hashimoto T., Slifstein M., Huang Y.",09698051,"Nuclear Medicine and Biology",27, 5,12,0,1,1,0,13
2000,"Age-related decline in central serotonin transporter availability with [123I]?-CIT SPECT","Van Dyck C.H., Malison R.T., Seibyl J.P., Laruelle M., Klumpp H., Zoghbi S.S., Baldwin R.M., Innis R.B.",01974580,"Neurobiology of Aging",21, 4,37,6,9,15,6,58
2000,"Hippocampal pathology in schizophrenia: Magnetic resonance imaging and spectroscopy studies","Kegeles L.S., Laruelle M., Kaufmann C.A., Shungu D.C., Anjilvel S., Chan S., Ellis S.P., Xanthopoulos E., Malaspina D., Gorman J.M., Mann J.J.",09254927,"Psychiatry Research - Neuroimaging",98, 3,31,2,0,2,2,35
2000,"Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review","Laruelle M.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",20, 3,274,49,43,92,32,398
2000,"Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: Validation and reproducibility","Abi-Dargham A., Lombarde I., Mann J.J., Van Heertum R., Foged C., Halldin C., Laruelle M., Martinez D., Mawlawi O., Simpson N., Hwang D.-R., Slifstein M., Anjilvel S., Pidcock J., Guo N.-N.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",20, 2,48,7,4,11,6,65
2000,"Low dopamine D2 receptor binding potential in social phobia","Schneier F.R., Liebowitz M.R., Abi-Dargham A., Zea-Ponce Y., Lin S.-H., Laruelle M.",0002953X,"American Journal of Psychiatry",157, 3,74,13,11,24,9,107
2000,"Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [123I]?-CIT","Laruelle M., Abi-Dargham A., Van Dyck C., Gil R., D'Souza D.C., Krystal J., Seibyl J., Baldwin R., Innis R.",00063223,"Biological Psychiatry",47, 5,44,8,6,14,4,62
2000,"The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies","Laruelle M.",01650173,"Brain Research Reviews",31, 2-3,109,25,22,47,9,165
2000,"[123I]IPCIT and [123I]?-CIT as SPECT tracers for the dopamine transporter: A comparative analysis in nonhuman primates","Scanley B.E., Innis R.B., Gandelman M.S., Laruelle M., Al-Tikriti M.S., Baldwin R.M., Zoghbi S.S., Hoffer P.B., Wang S., Neumeyer J.L.",09698051,"Nuclear Medicine and Biology",27, 1,3,0,0,0,0,3
1999,"Dopamine as the wind of the psychotic fire: New evidence from brain imaging studies","Laruelle M., Abi-Dargham A.",02698811,"Journal of Psychopharmacology",13, 4,85,18,23,41,14,140
1999,"Protein precipitation: an expedient procedure for the routine analysis of the plasma metabolites of [123I]IBZM","Zea-Ponce Y., Laruelle M.",09698051,"Nuclear Medicine and Biology",26, 7,2,0,1,1,0,3
1999,"An improved one-pot procedure for the preparation of [11C-carbonyl]-WAY100635","Hwang D.-R., Simpson N.R., Montoya J., Mann J.J., Laruelle M.",09698051,"Nuclear Medicine and Biology",26, 7,8,4,2,6,2,16
1999,"Synthesis of [123I]IBZM: A reliable procedure for routine clinical studies","Zea-Ponce Y., Laruelle M.",09698051,"Nuclear Medicine and Biology",26, 6,3,0,1,1,0,4
1999,"Coupling efficiency of brain ?-adrenergic receptors to G(s) protein in suicide, alcoholism and control subjects","Gurguis G.N.M., Turkka J., Laruelle M., Kleinman J., Linnoila M.",00333158,"Psychopharmacology",145, 1,9,1,0,1,0,10
1999,"Increased dopamine transmission in schizophrenia: relationship to illness phases","Laruelle M., Abi-Dargham A., Gil R., Kegeles L., Innis R.",00063223,"Biological Psychiatry",46, 1,145,36,31,67,25,237
1999,"Modelling: When and why?","Laruelle M.",03406997,"European Journal of Nuclear Medicine",26, 6,6,1,2,3,0,9
1999,"No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia","Abi-Dargham A., Charney D., Innis R.B., Laruelle M., Krystal J., D'Souza C., Zoghbi S., Baldwin R.M., Seibyl J., Mawlawi O., De Erasquin G.",0893133X,"Neuropsychopharmacology",20, 6,20,2,1,3,1,24
1999,"PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756","Abi-Dargham A., Mann J.J., Foged C., Halldin C., Laruelle M., Simpson N., Kegeles L., Parsey R., Hwang D.-R., Anjilvel S., Zea-Ponce Y., Lombardo I., Van Heertum R.",08874476,"Synapse",32, 2,60,7,3,10,5,75
1999,"Neuroimaging research and neurocircuitry models of obsessive-compulsive disorder: Proceedings of the Third IOCDC","Rauch S.L., Zohar J., Baxter L.R. Jr., Benkelfat C., Dager S.R., Greenberg B.D., Hendler T., Hollander E., Laruelle M., Rosenberg D.R., Saxena S.",10928529,"CNS Spectrums",4, 5,3,0,0,0,0,3
1999,"Synthesis of positron-labeled dopamine agonist [C-11]pramipexole and its derivatives","Hwang D.-R., Simpson N.R., Guo N.-N., Waterhouse R., Huang Y., Zea-Ponce Y., Mann J.J., Laruelle M.",03624803,"Journal of Labelled Compounds and Radiopharmaceuticals",42, 1,1,0,0,0,0,1
1998,"Imaging dopamine transmission in schizophrenia: A review and meta- analysis","Laruelle M.",11243937,"Quarterly Journal of Nuclear Medicine",42, 3,64,14,15,29,12,105
1998,"Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123i]iomazenil","Abi-Dargham A., Seibyl J.P., Charney D.S., Laruelle M., Innis R.B., Krystal J.H., Anjilvel S., Scanley B.E., Zoghbi S., Baldwin R.M., Rajeevan N., Ellis S., Petrakis I.L.",0002953X,"American Journal of Psychiatry",155, 11,56,5,6,11,1,68
1998,"Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort","Abi-Dargham A., Laruelle M., Gil R., Krystal J., Baldwin R.M., Seibyl J.P., Bowers M., Van Dyck C.H., Charney D.S., Innis R.B.",0002953X,"American Journal of Psychiatry",155, 6,197,43,30,73,27,297
1998,"D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene","Laruelle M., Gelernter J., Innis R.B.",13594184,"Molecular Psychiatry",3, 3,55,7,10,17,7,79
1997,"Imaging D2 receptor occupancy by endogenous dopamine in humans","Laruelle M., Jatlow P., Charney D.S., Innis R.B., D'Souza C.D., Baldwin R.M., Abi-Dargham A., Kanes S.J., Fingado C.L., Seibyl J.P., Zoghbi S.S., Bowers M.B.",0893133X,"Neuropsychopharmacology",17, 3,93,13,15,28,4,125
1997,"Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT(2A) receptors","Abi-Dargham A., Mertens J., Innis R.B., Zea-Ponce Y., Terriere D., Al-Tikriti M., Baldwin R.M., Hoffer P., Charney D., Leysen J.E., Laruelle M.",00142999,"European Journal of Pharmacology",321, 3,13,0,1,1,1,15
1997,"The role of serotonin in the pathophysiology and treatment of schizophrenia","Abi-Dargham A., Laruelle M., Aghajanian G.K., Charney D., Krystal J.",08950172,"Journal of Neuropsychiatry and Clinical Neurosciences",9, 1,90,8,8,16,4,110
1997,"Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates","Laruelle M., Hoffer P.B., Innis R.B., Bradberry C.W., Iyer R.N., Al-Tikriti M.S., Zea-Ponce Y., Malison R., Zoghbi S.S., Baldwin R.M., Kung H.F., Charney D.S.",08874476,"Synapse",25, 1,117,10,7,17,8,142
1996,"Images in neuroscience. SPECT imaging of synaptic dopamine.","Laruelle M., Innis R.B.",0002953X,"The American journal of psychiatry",153, 10,0,0,0,0,1,1
1996,"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","Laruelle M., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B., Abi-Dargham A., Van Dyck C.H., Gil R., D'Souza C.D., Erdos J., Mccance E., Rosenblatt W., Fingado C.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",93, 17,372,56,54,110,43,525
1996,"Spect imaging of dopamine transporters in human brain with iodine-123- fluoroalkyl analogs of ?-CIT","Abi-Dargham A., Neumeyer J.L., Innis R.B., Gandelman M.S., DeErausquin G.A., Zea-Ponce Y., Zoghbi S.S., Baldwin R.M., Laruelle M., Charney D.S., Hoffer P.B.",01615505,"Journal of Nuclear Medicine",37, 7,53,5,7,12,1,66
1996,"Reproducibility of iodine-123-?-CIT SPECT brain measurement of dopamine transporters","Seibyl J.P., Hoffer P.B., Innis R.B., Laruelle M., Van Dyck C.H., Wallace E., Baldwin R.M., Zoghbi S., Zea-Ponce Y., Neumeyer J.L., Charney D.S.",01615505,"Journal of Nuclear Medicine",37, 2,52,0,1,1,1,54
1996,"SPECT imaging of synaptic dopamine","Laruelle M., Innis R.B.",0002953X,"American Journal of Psychiatry",153, 10,1,0,0,0,0,1
1996,"Serotonin and schizophrenia: A review","Abi-Dargham A., Laruelle M., Charney D., Krystal J.",00257656,"Drugs of Today",32, 2,8,0,0,0,0,8
1995,"Euphorigenic doses of cocaine reduce [123I]?-CIT SPECT measures of dopamine transporter availability in human cocaine addicts","Malison R.T., Price L.H., Kosten T.R., Innis R.B., Best S.E., Wallace E.A., McCance E., Laruelle M., Zoghbi S.S., Baldwin R.M., Seibyl J.S., Hoffer P.B.",00333158,"Psychopharmacology",122, 4,32,3,1,4,0,36
1995,"Comparison of [123I]?-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates","Scanley B.E., Wang S., Neumeyer J.L., Innis R.B., Al-Tikriti M.S., Gandelman M.S., Laruelle M., Zea-Ponce Y., Baldwin R.M., Zogbni S.S., Hoffer P.B., Charney D.S.",03406997,"European Journal of Nuclear Medicine",22, 1,12,1,0,1,0,13
1995,"Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil","Abi-Dargham A., Innis R.B., Gandelman M., Zoghbi S.S., Laruelle M., Baldwin R.M., Randall P., Zea-Ponce Y., Charney D.S., Hoffer P.B.",01615505,"Journal of Nuclear Medicine",36, 2,43,1,1,2,0,45
1995,"Simplified multidose preparation of iodine-123-?-CIT: A marker for dopamine transporters","Zea-Ponce Y., Baldwin R.M., Laruelle M., Wang S., Neumeyer J.L., Innis R.B.",01615505,"Journal of Nuclear Medicine",36, 3,28,0,0,0,0,28
1995,"SPECT imaging of striatal dopamine release after amphetamine challenge","Laruelle M., Kung H.F., Innis R.B., Abi-Dargham A., Van Dyck C.H., Rosenblatt W., Zea-Ponce Y., Zoghbi S.S., Baldwin R.M., Charney D.S., Hoffer P.B.",01615505,"Journal of Nuclear Medicine",36, 7,139,10,15,25,6,170
1995,"Age-related decline in striatal dopamine transporter binding with iodine- 123-?-CIT SPECT","Van Dyck C.H., Hoffer P.B., Innis R.B., Seibyl J.P., Malison R.T., Laruelle M., Wallace E., Zoghbi S.S., Zea-Ponce Y., Baldwin R.M., Charney D.S.",01615505,"Journal of Nuclear Medicine",36, 7,146,5,6,11,6,163
1995,"Characterization of the dopamine transporter in nonhuman primate brain: Homogenate binding, whole body imaging, and ex vivo autoradiography using [125I] and [123I]IPCIT","Al-Tikriti M.S., Hoffer P.B., Sparks R., Stubbs J., Wang S., Neumeyer J.L., Innis R.B., Zea-Ponce Y., Baldwin R.M., Zoghbi S.S., Laruelle M., Seibyl J.P., Giddings S.G., Scanley B.E., Charney D.S.",09698051,"Nuclear Medicine and Biology",22, 5,5,0,0,0,0,5
1994,"SPECT imaging of dopamine and serotonin transporters in nonhuman primate brain","Laruelle M., Baldwin R.M., Innis R.B.",10469516,"NIDA Research Monograph Series",, 138,2,0,2,2,0,4
1994,"Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates","Baldwin R.M., Hoffer P.B., Innis R.B., Zea-Ponce Y., Zoghbi S.S., Al-Tikriti M.S., Seibyl J.P., Sybirska E.H., Malison R.T., Laruelle M., Charney D.S.",09698051,"Nuclear Medicine and Biology",21, 7,12,0,0,0,0,12
1994,"Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor","Al-Tikriti M.S., Charney D.S., Hoffer P.B., Innis R.B., Baldwin R.M., Zea-Ponce Y., Sybirska E., Zoghbi S.S., Laruelle M., Malison R.T., Kung H.F., Kessler R.M.",09698051,"Nuclear Medicine and Biology",21, 2,16,2,0,2,0,18
1994,"Active and inactive enantiomers of 2?-carbomethoxy-3?-(4- iodophenyl)tropane: Comparison using homogenate binding and single photon emission computed tomographic imaging","Scanley B.E., Wang S., Gao Y., Neumeyer J.L., Innis R.B., Baldwin R.M., Laruelle M., Al-Tikriti M.S., Zea-Ponce Y., Zoghbi S., Giddings S.S., Charney D.S., Hoffer P.B.",0026895X,"Molecular Pharmacology",45, 1,3,1,0,1,0,4
1994,"Methyl 3?-(4-[125I]iodophenyl)tropane-2?-carboxylate in vitro binding to dopamine and serotonin transporters under 'physiological' conditions","Laruelle M., Giddings S.S., Zea-Ponce Y., Charney D.S., Neumeyer J.L., Baldwin R.M., Innis R.B.",00223042,"Journal of Neurochemistry",62, 3,34,8,2,10,0,44
1994,"Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects","Laruelle M., Innis R.B., Van Dyck C., Abi-Dargham A., Zea-Ponce Y., Zoghbi S.S., Charney D.S., Baldwin R.M., Hoffer P.B., Kung H.F.",01615505,"Journal of Nuclear Medicine",35, 5,61,5,2,7,3,71
1994,"In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzafuran and single photon emission computerized tomography","Laruelle M., Al-Tikriti M.S., Zea-Ponce Y., Zoghbi S.S., Baldwin R.M., Charney D.S., Hoffer P.B., Kung H.F., Innis R.B.",00142999,"European Journal of Pharmacology",263, 1-2,24,1,0,1,0,25
1994,"Structure-activity relationships of dopamine transporter ligands: Stereospecificity in binding of 2?-carbomethoxy-3?-phenyltropane analogs","Baldwin R.M., Gao Y., Neumeyer I.L., Innis R.B., Laruelle M., Scanley B.E., Al-Tikriti M., Zea-Ponce Y., Zoghbi S.S., Charney D.S., Hoffer P.B., Wang S.",03624803,"Journal of Labelled Compounds and Radiopharmaceuticals",35, ,0,0,0,0,0,0
1994,"SPECT measurement of benzodiazepine receptors in human brain with iodine- 123-iomazenil: Kinetic and equilibrium paradigms","Abi-Dargham A., Charney D.S., Hoffer P.B., Innis R.B., Laruelle M., Seibyl J., Rattner Z., Baldwin R.M., Zoghbi S.S., Zea-Ponce Y., Bremner J.D., Hyde T.M.",01615505,"Journal of Nuclear Medicine",35, 2,100,1,1,2,3,105
1994,"SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters","Laruelle M., Abi-Dargham A., Al-Tikriti M.S., Baldwin R.M., Zea-Ponce Y., Zoghbi S.S., Charney D.S., Hoffer P.B., Innis R.B.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",14, 3,57,4,2,6,0,63
1994,"Graphical, kinetic, and equilibrium analyses of in vivo [123I]?-CIT binding to dopamine transporters in healthy human subjects","Laruelle M., Innis R.B., Wallace E., Seibyl J.P., Baldwin R.M., Zea-Ponce Y., Zoghbi S.S., Neumeyer J.L., Charney D.S., Hoffer P.B.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",14, 6,199,8,9,17,6,222
1994,"SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments","Laruelle M., Hoffer P.B., Innis R.B., Baldwin R.M., Rattner Z., Al-Tikriti M.S., Zea-Ponce Y., Zoghbi S.S., Charney D.S., Price J.C., Frost J.J.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",14, 3,59,0,2,2,1,62
1993,"Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease","Innis R.B., Wang S., Gao Y., Neumeyer J.L., Charney D.S., Hoffer P.B., Marek K.L., Seibyl J.P., Scanley B.E., Laruelle M., Abi-Dargham A., Wallace E., Baldwin R.M., Zea-Ponce Y., Zoghbi S.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",90, 24,248,17,5,22,8,278
1993,"Enantioselectivity of cocaine recognition sites: Binding of (1S)- and (1R)-2?-carbomethoxy-3?-(4-iodophenyl)tropane (?-CIT) to monoamine transporters","Wang S., Gao Y., Laruelle M., Baldwin R.M., Ellen Scanley B., Innis R.B., Neumeyer J.L.",00222623,"Journal of Medicinal Chemistry",36, 13,18,0,0,0,0,18
1993,"Pharmacological and regional characterization of [3H]LY278584 binding sites in human brain","Abi-Dargham A., Laruelle M., Wong D.T., Robertson D.W., Weinberger D.R., Kleinman J.E.",00223042,"Journal of Neurochemistry",60, 2,23,1,2,3,1,27
1993,"Single photon emission tomography measurement of benzodiazepine receptor number and affinity in primate brain: A constant infusion paradigm with [123I]iomazenil","Laruelle M., Hoffer P.B., Baldwin R.M., Innis R.B., Abi-Dargham A., Rattner Z., Al-Tikriti M.S., Zea-Ponce Y., Zoghbi S.S., Charney D.S., Price J., Frost J.J.",00142999,"European Journal of Pharmacology",230, 1,15,0,0,0,0,15
1993,"SPECT imaging of dopamine and serotonin transporters with [123I]?- CIT: Pharmacological characterization of brain uptake in nonhuman primates","Laruelle M., Neumeyer J.L., Milius R.A., Wang S., Smith E.O., Roth R.H., Charney D.S., Hoffer P.B., Innis R.B., Baldwin R.M., Malison R.T., Zea-Ponce Y., Zoghbi S.S., Al-Tikriti M.S., Sybirska E.H., Zimmermann R.C., Wisniewski G.",08874476,"Synapse",13, 4,202,14,11,25,9,236
1993,"Serotonin 5-HT3 receptors in schizophrenia: A postmortem study of the amygdala","Abi-Dargham A., Laruelle M., Lipska B., Jaskiw G.E., Wong D.T., Robertson D.W., Weinberger D.R., Kleinman J.E.",00068993,"Brain Research",616, 1-2,8,1,0,1,1,10
1993,"Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: A postmortem study","Laruelle M., Abi-Dargham A., Casanova M.F., Toti R., Weinberger D.R., Kleinman J.E.",0003990X,"Archives of General Psychiatry",50, 10,125,4,7,11,4,140
1992,"Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates","Zoghbi S.S., Malison R.T., Zimmerman R., Charney D.S., Smith E.O., Hoffer P.B., Innis R.B., Baldwin R.M., Seibyl J.P., Al-Tikriti M.S., Zea-Ponce Y., Laruelle M., Sybirska E.H., Woods S.W., Goddard A.W.",08832897,"International Journal of Radiation Applications and Instrumentation.",19, 8,0,0,0,0,0,0
1992,"Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates","Zoghbi S.S., Malison R.T., Zimmerman R., Charney D.S., Smith E.O., Hoffer P.B., Innis R.B., Baldwin R.M., Seibyl J.P., Al-Tikriti M.S., Zea-Ponce Y., Laruelle M., Sybirska E.H., Woods S.W., Goddard A.W.",08832897,"Nuclear Medicine and Biology",19, 8,33,0,1,1,0,34
1992,"Binding of serotonergic ligands to brain membranes of alcohol-preferring AA and alcohol-avoiding ANA rats","Korpi E.R., Paivarinta P., Abi-Dargham A., Honkanen A., Laruelle M., Tuominen K., Hilakivi L.A.",07418329,"Alcohol",9, 5,24,0,0,0,0,24
1992,"Abnormalities of serotonergic neural transmission in prefrontal cortex in schizophrenia.","Kleinman J.E., Laruelle M., Joyce J.N., Casanova M.F.",03625664,"Clinical Neuropharmacology",15, ,2,0,0,0,0,2
1992,"Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates","Innis R.B., Smith E.O., Charney D.S., Heninger G., Elsworth J.D., Roth R.H., Malison R.T., Al-Tikriti M., Hoffer P.B., Sybirska E.H., Seibyl J.P., Zoghbi S.S., Baldwin R.M., Laruelle M.",08874476,"Synapse",10, 3,93,7,3,10,2,105
1991,"[123I]-2?-carbomethoxy-3?-(4-iodophenyl)tropane: High-affinity SPECT radiotracer of monoamine reuptake sites in brain","Neumeyer J.L., Malison R.T., Laruelle M., Innis R.B., Wang S., Milius R.A., Baldwin R.M., Zea-Ponce Y., Hoffer P.B., Sybirska E., Al-Tikriti M., Charney D.S.",00222623,"Journal of Medicinal Chemistry",34, 10,144,9,6,15,3,162
1991,"Characterization of [125I]SCH 23982 binding in human brain: Comparison with [3H]SCH 23390","Laruelle M., Sidhu A., Casanova M.F., Weinberger D.R., Kleinman J.E.",03043940,"Neuroscience Letters",131, 2,7,2,0,2,0,9
1991,"SPECT imaging of the benzodiazepine receptor: Feasibility of in vivo potency measurements from stepwise displacement curves","Innis R.B., Johnson E.W., Smith E.O., Charney D.S., Heninger G.R., Woods S.W., Hoffer P.B., Al-Tikriti M.S., Zoghbi S.S., Baldwin R.M., Sybirska E.H., Laruelle M.A., Malison R.T., Seibyl J.P., Zimmermann R.C.",01615505,"Journal of Nuclear Medicine",32, 9,34,0,0,0,0,34
1991,"Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT","Innis R., Wisniewski G., Hoffer P., Wang S., Milius R., Neumeyer J., Baldwin R., Sybirska E., Zea Y., Laruelle M., Al-Tikriti M., Charney D., Zoghbi S., Smith E.",00142999,"European Journal of Pharmacology",200, 2-3,56,4,4,8,3,67
1989,"Regional distribution of serotonergic pre- and postsynaptic markers in human brain","Laruelle M., Maloteaux J.M.",00651591,"Acta Psychiatrica Scandinavica, Supplement",80, 350,11,1,0,1,0,12
1988,"Regional and subcellular localization in human brain [3H]paroxetine binding, a marker of serotonin uptake sites","Laruelle M., Vanisberg M.-A., Maloteaux J.-M.",00063223,"Biological Psychiatry",24, 3,84,6,2,8,4,96
